European medical device manufacturers are accelerating their adoption of artificial intelligence to drive digital transformation across regulatory operations and enhance patient safety, according to ISG. The shift reflects a broader industry trend toward leveraging AI to streamline compliance processes, reduce time-to-market for new devices, and improve the accuracy of clinical data analysis. By integrating AI-powered tools into quality management systems and regulatory submissions, companies are achieving greater efficiency and consistency in meeting stringent EU and international standards. These advancements also enable real-time monitoring of device performance post-launch, supporting faster identification of potential safety issues. As regulatory frameworks evolve—particularly under the EU Medical Device Regulation (MDR)—AI is proving instrumental in managing complex documentation, automating risk assessments, and ensuring traceability across supply chains. Industry experts note that early adopters are already seeing measurable improvements in audit readiness and regulatory approval timelines. With AI becoming a cornerstone of innovation, European medical device makers are positioning themselves at the forefront of a smarter, safer, and more agile healthcare technology ecosystem.